Company Filing History:
Years Active: 1991-2000
Title: Innovations of Jurgen Romisch: A Pioneer in Coagulation Research
Introduction
Jurgen Romisch, an esteemed inventor based in Marburg, Germany, has made significant contributions to the field of biochemistry, particularly in the area of coagulation research. With a portfolio of seven patents, Romisch's innovative processes are pivotal in advancing medical diagnostics and treatments related to blood coagulation.
Latest Patents
Among Romisch's latest patents are two noteworthy inventions. The first is a process for quantifying glycosaminoglycans in antithrombin, which employs an innovative methodology to determine the levels of glycosaminoglycans in antithrombin III (ATIII)-containing solutions. This process increases the ionic strength of the solution to prevent interaction between ATIII and glycosaminoglycans, allowing for the removal of released ATIII and accurate quantification of the remaining glycosaminoglycan.
The second patent focuses on the quantification of activated coagulation factor VII (FVIIa). This method utilizes selective binding to immobilized soluble thromboplastin, facilitating accurate measurements of FVIIa levels in various solutions. These inventions hold great potential for improving clinical diagnostics and therapeutic strategies.
Career Highlights
Jurgen Romisch has a notable career with significant roles in prominent companies. He worked with Behringwerke Aktiengesellschaft and Behring Diagnostics GmbH, where he applied his expertise in coagulation and contributed to the development of innovative diagnostic tools. His experience in these companies has enriched his understanding of the practical applications of his inventions.
Collaborations
Throughout his career, Romisch has collaborated with esteemed colleagues such as Eckhard Schuler and Klaus Habenstein. These professional relationships have fostered a collaborative environment conducive to innovation and the development of cutting-edge solutions in the realm of coagulation science.
Conclusion
Jurgen Romisch exemplifies the spirit of innovation in the field of biochemistry. His contributions, particularly in the understanding and measurement of coagulation factors, reflect his commitment to enhancing medical diagnostic processes. With a solid portfolio of patents and a background of valuable collaborations, Romisch continues to be a significant figure in advancing the science of coagulation.